Align Aspartate--tRNA(Asp/Asn) ligase; Aspartyl-tRNA synthetase; AspRS; Non-discriminating aspartyl-tRNA synthetase; ND-AspRS; EC 6.1.1.23 (characterized)
to candidate WP_011869534.1 MMARC5_RS09215 aspartate--tRNA(Asn) ligase
Query= SwissProt::O26328 (437 letters) >NCBI__GCF_000016125.1:WP_011869534.1 Length = 438 Score = 545 bits (1403), Expect = e-159 Identities = 262/436 (60%), Positives = 333/436 (76%) Query: 2 LLGDLRRTHYSKDIEPEMDGDEVTVMGWVHEIRDLGGIIFVLLRDRDGLIQITAPSKKIE 61 L+ D RRTHYS+++ PEMDG EV +MGWVH IR LG + FV+LRDR+G IQ P +K++ Sbjct: 3 LIADWRRTHYSEEVIPEMDGQEVILMGWVHSIRALGKLAFVILRDREGTIQAVVPKQKVD 62 Query: 62 KDLFKSIRKLKKESVVAFGGTVQESGKAPGGFEIIPSFLKVLNISKQPLPLDPTEKVKAE 121 ++ F +KL KE ++A G V + KAP GFE+IP ++VLN + PLPLDP+EKV AE Sbjct: 63 EETFAIAKKLGKEDIIAIRGKVVANEKAPKGFEVIPIEIRVLNKADAPLPLDPSEKVAAE 122 Query: 122 IDTRLDARFLDLRKPSVSAIFKIKSRMLHSVRVFLEEQGFLEINTPKLVASATEGGTELF 181 IDTRLD RFLD+R+P + AIFKI+S ML S+R + GF+E+NTPKLVASATEGGTELF Sbjct: 123 IDTRLDKRFLDIRRPKIQAIFKIRSEMLRSIRKTFADGGFVEVNTPKLVASATEGGTELF 182 Query: 182 PITYFEREAFLGQSPQLYKQIMMSTGLDRVYEIAPIFRAEEHDTLRHLNEVISIDIEASF 241 PI+YFE+EAFLGQSPQLYKQ+MM+ G D+V+EIA IFRAEEH+T RHLNE ISID E SF Sbjct: 183 PISYFEKEAFLGQSPQLYKQMMMAGGFDKVFEIAQIFRAEEHNTRRHLNEAISIDTEMSF 242 Query: 242 VDHEDVMKILENLVVRVIEDVNEHCTDALETLGRTLEVPETPFERLEYDEAVEMVNSKGV 301 V+ +D M +LE +V D+ + +E L E+PE F+++ Y EA+++ N+KGV Sbjct: 243 VNEKDAMAMLEKVVYNCYADIEYNRPQEIELLELNWEIPEKTFDKITYTEAIDIANAKGV 302 Query: 302 PMKHGEDLPRAAEKALGEIMDGYYFITSWPTAIKPFYVMPDEDDPERSHAFDLMYRDLEI 361 ++ GEDL RAAE+A+G+ M G YFIT WPT +PFY +P + D + AFDLMY++LEI Sbjct: 303 EIEWGEDLSRAAERAVGDEMGGLYFITEWPTQTRPFYTLPHKHDNKVCKAFDLMYKELEI 362 Query: 362 SSGAMRVHQHDLLVEKIKRQGLNPDSFESYLSAFEYGMPPHAGWGLGAERFNMTLTGLKN 421 SSGA RVH++DLLVE I G+NPDSFE+YL AF++GMPPHAGWGLGA+RF M LT N Sbjct: 363 SSGAQRVHKYDLLVENISNMGMNPDSFETYLEAFKFGMPPHAGWGLGADRFAMVLTAQDN 422 Query: 422 IRETVLFPRDRRRLTP 437 IRE VLFPRDR+RLTP Sbjct: 423 IRECVLFPRDRQRLTP 438 Lambda K H 0.320 0.139 0.402 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 550 Number of extensions: 20 Number of successful extensions: 1 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 437 Length of database: 438 Length adjustment: 32 Effective length of query: 405 Effective length of database: 406 Effective search space: 164430 Effective search space used: 164430 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 51 (24.3 bits)
Align candidate WP_011869534.1 MMARC5_RS09215 (aspartate--tRNA(Asn) ligase)
to HMM TIGR00458 (aspS: aspartate--tRNA(Asn) ligase (EC 6.1.1.23))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR00458.hmm # target sequence database: /tmp/gapView.1210049.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR00458 [M=428] Accession: TIGR00458 Description: aspS_nondisc: aspartate--tRNA(Asn) ligase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 7.7e-215 699.7 0.5 8.7e-215 699.5 0.5 1.0 1 NCBI__GCF_000016125.1:WP_011869534.1 Domain annotation for each sequence (and alignments): >> NCBI__GCF_000016125.1:WP_011869534.1 # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 699.5 0.5 8.7e-215 8.7e-215 1 428 [] 11 438 .] 11 438 .] 1.00 Alignments for each domain: == domain 1 score: 699.5 bits; conditional E-value: 8.7e-215 TIGR00458 1 vysadikeekdgkevllrgwvheirdlGalifvllrdregliqilvkkkkvskelfklikklkkesvvavkGk 73 +ys ++ +e+dg+ev+l+gwvh+ir+lG+l+fv+lrdreg+iq +v+k+kv++e f +kkl ke+++a++Gk NCBI__GCF_000016125.1:WP_011869534.1 11 HYSEEVIPEMDGQEVILMGWVHSIRALGKLAFVILRDREGTIQAVVPKQKVDEETFAIAKKLGKEDIIAIRGK 83 79999******************************************************************** PP TIGR00458 74 vkekekapqgleiipeklevlneakeplPldleekveaeldtrldarfldlrrpkvqaifkirsevlesvref 146 v ++ekap+g+e+ip +++vln+a++plPld++ekv ae+dtrld+rfld+rrpk+qaifkirse+l+s+r++ NCBI__GCF_000016125.1:WP_011869534.1 84 VVANEKAPKGFEVIPIEIRVLNKADAPLPLDPSEKVAAEIDTRLDKRFLDIRRPKIQAIFKIRSEMLRSIRKT 156 ************************************************************************* PP TIGR00458 147 laeegfievntPklvasateGGtelfeityfereaflaqsPqlykqvllaaglervyeiaPifraeehntkrh 219 +a+ gf+evntPklvasateGGtelf+i+yfe+eafl+qsPqlykq+++a g+++v+eia ifraeehnt+rh NCBI__GCF_000016125.1:WP_011869534.1 157 FADGGFVEVNTPKLVASATEGGTELFPISYFEKEAFLGQSPQLYKQMMMAGGFDKVFEIAQIFRAEEHNTRRH 229 ************************************************************************* PP TIGR00458 220 lnevisidiemafedhkdvldileelvvrvfedvaeklkkelevlevklevpeeklerltydeaieilrakGk 292 lne+isid em+f+++kd++ +le++v++ + d++ ++ +e+e+le++ e+pe+ ++++ty eai+i++akG+ NCBI__GCF_000016125.1:WP_011869534.1 230 LNEAISIDTEMSFVNEKDAMAMLEKVVYNCYADIEYNRPQEIELLELNWEIPEKTFDKITYTEAIDIANAKGV 302 ************************************************************************* PP TIGR00458 293 eikdgedlsteaekllGekmdglyfitdfPteikPfytmPdednPeisksfdllyrdleissGaqrihdydll 365 ei++gedls++ae+++G++m+glyfit++Pt+ +Pfyt+P++++ +++k+fdl+y++leissGaqr+h+ydll NCBI__GCF_000016125.1:WP_011869534.1 303 EIEWGEDLSRAAERAVGDEMGGLYFITEWPTQTRPFYTLPHKHDNKVCKAFDLMYKELEISSGAQRVHKYDLL 375 ************************************************************************* PP TIGR00458 366 vekikakGlePeslksyleafkyGmPPhaGwGlGaerlvmvlldlknireavlfPrdrkrltP 428 ve+i + G++P+s+++yleafk+GmPPhaGwGlGa+r+ mvl+ ++nire+vlfPrdr+rltP NCBI__GCF_000016125.1:WP_011869534.1 376 VENISNMGMNPDSFETYLEAFKFGMPPHAGWGLGADRFAMVLTAQDNIRECVLFPRDRQRLTP 438 **************************************************************9 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (428 nodes) Target sequences: 1 (438 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.00u 0.01s 00:00:00.01 Elapsed: 00:00:00.01 # Mc/sec: 14.50 // [ok]
This GapMind analysis is from Jul 25 2024. The underlying query database was built on Jul 25 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory